Today: 27 June 2026
Bombay Stock Exchange Weekend Update: Sensex Slips to 85,041 as Investors Eye Monday’s Cues on FII Flows, Rupee and BSE Derivatives
28 December 2025
6 mins read

Bombay Stock Exchange Weekend Update: Sensex Slips to 85,041 as Investors Eye Monday’s Cues on FII Flows, Rupee and BSE Derivatives

NEW YORK, Dec. 28, 2025, 8:48 a.m. ET — Market closed

With U.S. markets shut for the weekend and Dalal Street also closed, the focus shifts to what moves next when the Bombay Stock Exchange (BSE) reopens for the final stretch of 2025 trading. Friday’s session ended with a familiar late-December cocktail: thin participation, profit-taking near record highs, and persistent foreign selling pressure—tempered by pockets of sector strength and a derivatives story at BSE that’s getting harder for global investors to ignore.

Where the BSE Sensex left off: year-end profit-taking trims weekly gains

India’s benchmark BSE Sensex fell 0.43% on Friday to close at 85,041.45, while the Nifty 50 ended at 26,042.3 (down 0.38%). The dip pared back what still amounted to modest weekly gains—important mainly because they snapped a multi-week losing run and kept benchmarks hovering close to record territory.

Market participants pointed to year-end conditions rather than a single headline catalyst: liquidity thins out, positioning becomes more fragile, and “normal” flows can look dramatic. Reuters noted that average daily volumes in December for Nifty 50 stocks have run below the prior month’s pace—one reason price action can feel oddly calm even when underlying risk is not. Reuters

Siddhartha Khemka, head of research (wealth management) at Motilal Oswal Financial Services, described the tone as continued consolidation near record highs amid muted year-end activity, adding that the next leg higher may require stronger corporate updates and/or a fresh macro trigger.

The foreign flow problem hasn’t gone away—and it’s colliding with FX reality

One of the loudest signals into Monday isn’t a single stock—it’s the tug-of-war between foreign portfolio investors and domestic flows, and the way that battle shows up in the currency.

On the FX front, the Indian rupee ended the week weaker at 89.85 per U.S. dollar, down about 0.6% over the week, as corporate dollar demand and non-deliverable forward (NDF) market dynamics eroded the prior intervention-led bounce. ANZ analysts said they expect gradual depreciation until a favorable U.S. trade deal improves the backdrop—and that even if the rupee strengthens, the Reserve Bank of India may use the opportunity to add to reserves.

That matters directly for equities: a softer rupee can pressure foreign returns and can amplify risk-off behavior when global investors are already cautious.

The equity flow story looks even starker in the year-end totals. The Economic Times reported that foreign institutional investors were on track for a record net exit in 2025—about ₹1.58 lakh crore of net outflows as of Dec. 27—citing Geojit Financial Services’ Chief Investment Strategist V.K. Vijayakumar, who called it the worst selling since FIIs began investing in India.

Week-ahead setup: derivatives expiry, key data, and global Fed cues

If the market has felt sleepy, the calendar is trying to wake it up.

Indian market watchers are highlighting derivatives-related volatility risk into the turn of the year. Ajit Mishra, SVP (research) at Religare Broking, told The Times of India that the week’s transition into the new calendar year could bring heightened volatility tied to the month-end derivatives setup, while attention also turns to industrial production data and the final HSBC manufacturing PMI reading. He also flagged U.S. signals—particularly FOMC minutes—as an important global cue.

From a U.S. perspective, Reuters’ “Week Ahead” coverage framed markets as sitting near record highs into year-end, with investors watching how the Federal Reserve’s path (and the minutes that illuminate it) influences rates, risk appetite, and leadership rotation. Those themes matter to India because they feed directly into global allocation decisions—especially when currency volatility is already on the radar. Reuters

Meanwhile, Reuters’ global markets wrap underscored that U.S. equities ended close to record peaks in muted post-holiday trading, while precious metals pushed to record highs on rate-cut expectations and safe-haven demand—another reminder that “quiet tape” doesn’t always mean “low risk.” Reuters

Technical picture: calm on the surface, tension underneath

A big psychological storyline into Monday is whether benchmarks can stabilize above key round-number supports—or whether thin liquidity turns a small move into something messier.

Economic Times contributor Milan Vaishnav highlighted a striking feature of the recent environment: India VIX sliding to record lows (9.15), a level often associated with complacency and vulnerability to sudden volatility spikes. In his analysis, the market has been rangebound with narrowing breadth—conditions that can persist… right up until they don’t.

In a separate ETMarkets interview-style piece, Anand James, Chief Market Strategist at Geojit Investments, argued that weakness from record highs does not automatically signal a major trend break. He outlined a support cluster near 26,000 on the Nifty and suggested that a successful hold could fuel a sharper rebound attempt, while also detailing nearby support levels and warning what would open up if those levels fail. He also pointed to cautious foreign positioning—FIIs holding a relatively small share of index futures longs and maintaining meaningful shorts—suggesting the “flow fight” is still unresolved. The Economic Times

LiveMint, quoting Ganesh Dongre, Senior Manager of Technical Research at Anand Rathi, echoed the same basic map: 26,000 as the key psychological level, with the prior breakout zone (roughly 25,700–25,800) seen as a support base and resistance building in the 26,300–26,500 area.

The Bombay Stock Exchange story isn’t just the Sensex anymore

While the Sensex is the headline, the exchange itself—BSE Ltd.—has become part of the investable narrative, largely because of derivatives.

The Economic Times reported that under CEO Sundararaman Ramamurthy (since January 2023), BSE executed a sweeping turnaround driven by cost discipline, technology upgrades, and a deliberate push into equity derivatives—particularly Sensex weekly options. The report quotes Ramamurthy describing a ₹100 crore cost-cutting exercise early in his tenure and details a broad tech overhaul intended to reduce latency and scale capacity.

Crucially, ET wrote that BSE’s index options footprint has expanded meaningfully: citing Jefferies, the article said BSE’s market share in premium turnover for index options reached 28.4% in November, with notional turnover share also rising sharply versus a year earlier. That’s not a small footnote—it’s a structural shift in how trading activity (and exchange economics) can evolve in India’s market microstructure.

BSE’s product strategy is also visible in its index maintenance. ETMarkets reported that BSE Bankex was reconstituted effective Dec. 26, expanding to 14 constituents and adding banks including Canara Bank, AU Small Finance Bank, Punjab National Bank, and Union Bank of India—a move positioned as part of BSE’s broader effort to strengthen participation in its Sensex and Bankex derivatives ecosystem.

What investors should know before the next BSE session opens

Because markets are closed right now, the smartest preparation is less about prediction and more about avoiding surprise. Here’s the practical checklist investors and traders tend to watch heading into the next opening bell:

  • Currency first, headlines second: If the rupee shows renewed pressure (or volatility), it can quickly shape foreign flow expectations—especially after a week that ended with the rupee near 89.85 per dollar and with analysts warning of further downside risk.
  • Flow watch: Year-end positioning can exaggerate moves. Record-scale net FII outflows reported for 2025 make it harder to hand-wave foreign selling as “noise,” even if domestic bids remain supportive. The Economic Times+1
  • Derivatives can swing the tail: Expiry dynamics into the year’s close can turn small spot moves into larger intraday ranges—particularly in bank-heavy baskets and index options where liquidity is deepest.
  • Volatility is cheap—until it isn’t: With India VIX near record lows in recent analysis, markets may be pricing a smooth ride. Historically, that’s exactly when sharp spikes can blindside crowded positioning.
  • Watch the U.S. macro drumbeat: Even if India’s domestic story is steady, global risk sentiment can shift quickly around Fed communication, especially when U.S. equities are sitting near record levels into year-end.
  • BSE’s derivatives momentum is a real theme: Beyond the index level, BSE’s growing traction in index options—and its product/index adjustments like the Bankex reshuffle—are increasingly part of how investors evaluate India’s exchange landscape.

Bottom line: the BSE enters the final stretch in “rangebound mode,” but with big undercurrents

Friday’s Sensex close near 85,041 doesn’t scream panic. It whispers something more interesting: a market near highs that’s trying to levitate through year-end with lighter volumes, stubborn foreign selling, and a currency that won’t sit still.

Into Monday, the spotlight is likely to stay split between (1) whether key supports hold as liquidity returns, and (2) whether structural shifts—especially BSE’s expanding derivatives franchise—continue to reshape how global and domestic investors think about India’s market plumbing, not just its stock picking.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Rare €2 Coins to Check in 2025: The Truth About the 2002 Greek “S in the Star” and What’s Actually Worth Money
Previous Story

Rare €2 Coins to Check in 2025: The Truth About the 2002 Greek “S in the Star” and What’s Actually Worth Money

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Next Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Go toTop